Project: Precision medicine in inherited blindness using integrated omics in human and animal models
2020-01-01 – 2026-10-31
- Abstract
This multidisciplinary project aims (1) to decipher cis-regulation in human retina by chromatin conformation profiling, and by the study of regulatory elements in a human and animal model;; (2) to design an integrative framework for omics data analysis to explain missing heritability in inherited
blindness;; (3) to design and test antisense oligonucleotide-based treatments of novel targets, ultimately resulting in precision medicine for inherited blindness.
Show
Sort by
-
- Journal Article
- A1
- open access
saseR : juggling offsets unlocks RNA-seq tools for fast and scalable differential usage, aberrant splicing and expression retrieval
-
- Journal Article
- A1
- open access
Stochastic gradient descent estimation of generalized matrix factorization models with application to single-cell RNA sequencing data
-
- Journal Article
- A1
- open access
De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa
-
- Journal Article
- A1
- open access
Advancing DIA-based limited proteolysis workflows : introducing DIA-LiPA
-
- Journal Article
- A1
- open access
Precise, predictable genome integrations by deep-learning-assisted design of microhomology-based templates
-
- Journal Article
- A1
- open access
msqrob2TMT : robust linear mixed models for inferring differential abundant proteins in labeled experiments with arbitrarily complex
-
Dimensionality reduction and outlier detection for transcriptomics and proteomics data
(2025) -
- Journal Article
- A1
- open access
Generation and characterization of three human induced pluripotent stem cell lines (UGENTi005, UGENTi006 and UGENTi007) from patients with autosomal dominant adult-onset maculopathy due to RPE65 variant c.1555G>A, p.(E519K)
-
- Journal Article
- A1
- open access
RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals
-
- Journal Article
- A1
- open access
Cracking rare disorders : a new minimally invasive RNA-seq protocol